Company
United StatesPublic company, NYSE: PFEPfizer Inc (NYSE: PFE), Peapack, NJ – FDA Inspections
Inspection records and compliance data for Pfizer Inc in Peapack, New Jersey. 3 FDA inspections on record, last inspected September 08, 2017. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer Inc based in Peapack, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected June 10, 2010. Last inspected September 8, 2017.
Most cited issue areas
- Contamination, chemical or physical change, deterioration1 inspection
- Failure to meet specifications1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 8, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1028820 |
| August 31, 2010 | VAI | Human Drugs · Drug Quality Assurance | 678492 |
| June 10, 2010 | VAI | Human Drugs · Drug Quality Assurance | 668103 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer Inc
Stock ticker
PFE
Exchange
NYSE
Share price
$29.91
Market cap
$170.5B
Price as of
November 6, 2026
FEI Number
3004945409
Address
100 North Route 206, Peapack, New Jersey 07977, United States
Country
United States
ID: 2789218e-b17d-494f-8132-63b8925721fd